GLP-1s could cause beer sales to decline, report says
Options Heineken advised its customers to pursue are half-pints, low- and no-alcohol options, according to the publication. Heineken has warned that the popularity of GLP-1 medications could cause beer sales to decrease. The company has presented a document to UK hospitality customers warning that the medications could potentially change drinking habits among users. The drugs, which reduce alcohol cravings and consumption, may result in "fullness and fewer serves" in pubs and bars. Heineken's research found consumers are increasingly choosing smaller servings, lower-alcohol beverages and premium products, aligning with broader trends focused on health, wellness and moderation. Other brewers, including Diageo, Carlsberg and Damm, disagreed with the warning, stating it would be difficult for them to pursue a GLP/1-focused strategy.
Diterbitkan : 3 jam yang lalu oleh Rob Taub di dalam Business Health
(NewsNation) — One benefit reported by people taking GLP-1 medications is a reduction in alcohol cravings and consumption, but the drugs’ growing popularity has created new challenges for beer compani... [1866 symbols]
